News | October 09, 2024
Briefs: NATCO Pharma, Mylan Pharmaceuticals, Novo Nordisk and Alembic Pharmaceuticals
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
Strategic focus on COCO-model with a nationwide reach of 501 stores
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
India has taken the lead in recognising NAFLD as a major non-communicable disease
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Subscribe To Our Newsletter & Stay Updated
